Shilpa Gupta Expresses Her Excitement for IBCG25 Under the Leadership of Ashish M. Kamat
Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post by Ashish M. Kamat, Professor of Urologic Oncology (Surgery) and Cancer Research at University of Texas MD Anderson Cancer Center, on X:
”Looking forward to the 3rd IBCG meeting, truly a global effort with experts around the world gathering together to brainstorm and provide consensus on important questions pertaining to bladder cancer.
Kudos to terrific leadership by Ashish M. Kamat.
Honored to be a part of this community!”
Quoting Ashish M. Kamat’s post:
“Thrilled to welcome over 100 global experts and patient advocates to Houston for IBCG25! Together we’ll focus on two crucial goals: integrating bladder cancer biomarkers into clinical practice, and developing tools to better monitor and address local bladder toxicity – guided by the patient voice. Both topics reflect our International Bladder Cancer Group (IBCG) mission: to create real-world solutions that improve outcomes and provide practical tools for patients worldwide; through collaboration, collaboration and … more collaboration!”
More posts featuring Shilpa Gupta.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023